Webinar has been completed
2nd International conference on Next gen Biotech will be updated soon….
Welcome To
Next Gen Bio Tech 2025:
Innovations in Genomics, Bioengineering, and Therapeutics
Join the global community of biotechnology innovators for a transformative event—Next Gen Bio Tech 2025, where science meets future potential. This one-day virtual gathering is designed to spotlight the latest breakthroughs in Genomics, Bioengineering, and Therapeutics, bringing together thought leaders, researchers, clinicians, policy-makers, investors, and students from around the world.
About the Webinar
Next Gen Bio Tech 2025 is a future-forward webinar showcasing the emerging technologies, visionary research, and real-world applications reshaping biotechnology. Our event aims to bridge the gap between academic excellence, industrial innovation, and public health outcomes.
Core Topics
Next-Gen Bioengineering & Synthetic Biology
Precision Genomics & CRISPR 3.0
AI-Powered Drug Discovery
Cellular & Gene Therapies
mRNA Technology & Beyond
Biotech Startups & Commercialization Pathways
Sessions
Explores breakthroughs in genome editing, sequencing, and gene modulation driving personalized diagnostics and targeted therapeutics.
Covers AI-powered analysis, predictive modeling, and automation accelerating discovery in genomics, drug development, and molecular design.
Highlights how genomics, proteomics, and metabolomics integration reveal complex biological networks for precision healthcare.
Focuses on next-generation CRISPR, base, and prime editing tools redefining gene therapy and synthetic biology.
Discusses computational simulations, bioinformatics pipelines, and digital biology models transforming research and disease prediction.
Examines the rise of digital twin technologies for modeling biological systems and optimizing therapeutic responses.
Explores scalable data platforms and AI analytics improving efficiency in biological discovery and healthcare decision-making.
Covers cutting-edge sequencing technologies, faster data analysis, and real-time applications in clinical genomics.
Highlights the design of engineered biological systems and programmable cells for medicine, agriculture, and sustainability.
Explores breakthroughs in cell scaffolds, biomaterials, and tissue regeneration driving regenerative medicine advancements.
Covers process optimization, automation, and quality control in large-scale biologics and therapeutic manufacturing.
Discusses 3D bioprinting innovations for tissue fabrication, organ modeling, and precision regenerative healthcare.
Presents microfluidic platforms enabling high-throughput screening, diagnostics, and drug discovery miniaturization.
Focuses on smart biosensing technologies for disease detection, environmental monitoring, and personalized health tracking.
Examines nanomaterials and nanoscale systems improving targeted drug delivery, imaging, and regenerative therapy outcomes.
Explores machine learning approaches in process monitoring, yield prediction, and quality-by-design control systems.
Covers AI-aided target identification, molecular docking, and validation workflows accelerating new drug pipelines.
Highlights innovative vaccine technologies, adjuvant systems, and next-gen immune engineering approaches.
Focuses on clinical progress in CAR-T, stem cell, and gene therapy treatments transforming global healthcare.
Our Partners
- The global biotechnology market is projected to reach $3.88 trillion by 2030, growing at a CAGR of 13.9% from 2023 to 2030 (Source: Grand View Research).
- The genomics market alone is expected to surpass $94 billion by 2028, driven by advances in CRISPR, personalized medicine, and AI-powered data analysis.
- The bioengineering sector is seeing explosive growth, particularly in synthetic biology, which is expected to reach $45 billion by 2027.
- The therapeutics market, especially in gene and cell therapy, is projected to grow over 20% annually, with mRNA therapeutics expanding rapidly post-COVID.
- Investment in biotech startups reached over $60 billion globally in 2024, showing strong investor confidence in biotech’s transformative potential.
Speakers
Uthman Okikiola Adebayo
Dr. Gowri K
Department of Pharmacology since joining in 2010. Her passion lies in the
implementation of new methodologies, particularly alternative animal models, and
innovative techniques in research.